Effect of Intravenous Administration of Liposomal Prostaglandin E1 on Microcirculation in Patients with ST Elevation Myocardial Infarction Undergoing Primary Percutaneous Intervention

BACKGROUND: Several studies have demonstrated that primary percutaneous coronary intervention (PCI) can result in reperfusion injury. This study aims to investigate the effectiveness of liposomal prostaglandin E1 (Lipo-PGE1, Alprostadil, Beijing Tide Pharmaceutical Co., Ltd.) for enhancing microcirc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Li-Ye, Fu, Xiang-Hua, Li, Wei, Bi, Xi-Le, Bai, Shi-Ru, Xing, Kun, Wang, Yan-Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2015
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831538/
https://www.ncbi.nlm.nih.gov/pubmed/25947394
http://dx.doi.org/10.4103/0366-6999.156078

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4831538/
https://www.ncbi.nlm.nih.gov/pubmed/25947394
http://dx.doi.org/10.4103/0366-6999.156078

Ejemplares similares